Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Statements of Operations

v3.20.1
Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Income Statement [Abstract]    
Research and development expenses $ 755,699 $ 459,184
Marketing expenses 666,872
General and administrative expenses 2,092,645 919,694
Operating loss (3,515,216) (1,378,878)
Financing (income) expenses, net 5,333,498 (921,337)
Share in losses of affiliated company accounted for under equity method 2,965,801
Net loss $ (11,814,515) $ (457,541)
Basic and diluted net loss per share $ (0.13) $ (0.01)
Basic and diluted weighted average number of ordinary shares outstanding 92,024,188 70,869,924